OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis
Jessica Widdifield, Jeffrey C. Kwong, Simon Chen, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e430-e440
Open Access | Times Cited: 38
Jessica Widdifield, Jeffrey C. Kwong, Simon Chen, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e430-e440
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study
Malcolm Risk, Salim S. Hayek, Elena Schiopu, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 11, pp. e775-e784
Open Access | Times Cited: 48
Malcolm Risk, Salim S. Hayek, Elena Schiopu, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 11, pp. e775-e784
Open Access | Times Cited: 48
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
Naomi J. Patel, Xiaosong Wang, Xiaoqing Fu, et al.
Seminars in Arthritis and Rheumatism (2022) Vol. 58, pp. 152108-152108
Open Access | Times Cited: 36
Naomi J. Patel, Xiaosong Wang, Xiaoqing Fu, et al.
Seminars in Arthritis and Rheumatism (2022) Vol. 58, pp. 152108-152108
Open Access | Times Cited: 36
Factors Associated With an Electronic Health Record–Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease
Naomi J. Patel, Xiaosong Wang, Lin Miao, et al.
The Journal of Rheumatology (2024) Vol. 51, Iss. 5, pp. 529-537
Open Access | Times Cited: 5
Naomi J. Patel, Xiaosong Wang, Lin Miao, et al.
The Journal of Rheumatology (2024) Vol. 51, Iss. 5, pp. 529-537
Open Access | Times Cited: 5
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study
Jeremiah Tan, Sasha Bernatsky, Jennifer L. Lee, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 104-104
Open Access
Jeremiah Tan, Sasha Bernatsky, Jennifer L. Lee, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 104-104
Open Access
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE
Xuan Wang, Ankit Pahwa, Mary T. Bausch-Jurken, et al.
Advances in Therapy (2025)
Open Access
Xuan Wang, Ankit Pahwa, Mary T. Bausch-Jurken, et al.
Advances in Therapy (2025)
Open Access
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
Laura Boekel, Yaëlle R Besten, Femke Hooijberg, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 11, pp. e747-e750
Open Access | Times Cited: 19
Laura Boekel, Yaëlle R Besten, Femke Hooijberg, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 11, pp. e747-e750
Open Access | Times Cited: 19
Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
Alessandra Zaccardelli, Zachary S. Wallace, Jeffrey A. Sparks
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 3, pp. 175-184
Open Access | Times Cited: 11
Alessandra Zaccardelli, Zachary S. Wallace, Jeffrey A. Sparks
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 3, pp. 175-184
Open Access | Times Cited: 11
Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study
Carol Hitchon, Christine Mesa, Çharles N. Bernstein, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e071397-e071397
Open Access | Times Cited: 9
Carol Hitchon, Christine Mesa, Çharles N. Bernstein, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e071397-e071397
Open Access | Times Cited: 9
Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study
David Simón, Koray Taşçılar, Filippo Fagni, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 9, pp. e614-e625
Open Access | Times Cited: 15
David Simón, Koray Taşçılar, Filippo Fagni, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 9, pp. e614-e625
Open Access | Times Cited: 15
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications
Claire Cook, Naomi J. Patel, Xiaoqing Fu, et al.
The Journal of Rheumatology (2023) Vol. 50, Iss. 5, pp. 697-703
Open Access | Times Cited: 7
Claire Cook, Naomi J. Patel, Xiaoqing Fu, et al.
The Journal of Rheumatology (2023) Vol. 50, Iss. 5, pp. 697-703
Open Access | Times Cited: 7
Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study
Warren Fong, Ting Hui Woon, Li‐Ching Chew, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 7
Warren Fong, Ting Hui Woon, Li‐Ching Chew, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 7
Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis
Aakash Desai, Parakkal Deepak, Raymond K. Cross, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 10, pp. 1563-1571
Open Access | Times Cited: 11
Aakash Desai, Parakkal Deepak, Raymond K. Cross, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 10, pp. 1563-1571
Open Access | Times Cited: 11
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study
Anne-Marie Svensson, Hanne‐Dorthe Emborg, Lars Erik Bartels, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 10, pp. 1359-1367
Closed Access | Times Cited: 6
Anne-Marie Svensson, Hanne‐Dorthe Emborg, Lars Erik Bartels, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 10, pp. 1359-1367
Closed Access | Times Cited: 6
Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics
Dario Graceffa, Francesca Sperati, Claudio Bonifati, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Dario Graceffa, Francesca Sperati, Claudio Bonifati, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases
Yan Geng, Yong Fan, Xuerong Deng, et al.
Rheumatology and Therapy (2023) Vol. 10, Iss. 4, pp. 1039-1053
Open Access | Times Cited: 5
Yan Geng, Yong Fan, Xuerong Deng, et al.
Rheumatology and Therapy (2023) Vol. 10, Iss. 4, pp. 1039-1053
Open Access | Times Cited: 5
SARS-CoV-2 mRNA vaccine-induced immune responses in rheumatoid arthritis
Marc-André Limoges, Audrey Lortie, Élodie Demontier, et al.
Journal of Leukocyte Biology (2023) Vol. 114, Iss. 4, pp. 358-367
Open Access | Times Cited: 5
Marc-André Limoges, Audrey Lortie, Élodie Demontier, et al.
Journal of Leukocyte Biology (2023) Vol. 114, Iss. 4, pp. 358-367
Open Access | Times Cited: 5
TNF inhibitors significantly attenuate the humoral immune response to COVID-19 vaccination in patients with rheumatoid arthritis
Arne Schäfer, Magdolna Szilvia Kovacs, Anna Eder, et al.
Rheumatology Advances in Practice (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 5
Arne Schäfer, Magdolna Szilvia Kovacs, Anna Eder, et al.
Rheumatology Advances in Practice (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 5
Managing Patients with Immune-Mediated Inflammatory Diseases on Disease-Modifying Antirheumatic Drug Therapy in a COVID-19 Endemic World: A Narrative Review and Expert Insights
Kok Ooi Kong, Pinyo Rattanaumpawan, Nguyen Chau Tuan, et al.
(2024)
Open Access | Times Cited: 1
Kok Ooi Kong, Pinyo Rattanaumpawan, Nguyen Chau Tuan, et al.
(2024)
Open Access | Times Cited: 1
Neutralizing Antibody Response, Safety, and Efficacy of mRNA COVID-19 Vaccines in Pediatric Patients with Inflammatory Bowel Disease: A Prospective Multicenter Case—Control Study
Kyung Jae Lee, So Yoon Choi, Yoo Min Lee, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1265-1265
Open Access | Times Cited: 7
Kyung Jae Lee, So Yoon Choi, Yoo Min Lee, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1265-1265
Open Access | Times Cited: 7
Perspectives and experiences of COVID-19 vaccination in people with autoimmune and inflammatory rheumatic disease
David Peng, Ayano Kelly, Bernadette Brady, et al.
Patient Education and Counseling (2023) Vol. 118, pp. 107996-107996
Open Access | Times Cited: 3
David Peng, Ayano Kelly, Bernadette Brady, et al.
Patient Education and Counseling (2023) Vol. 118, pp. 107996-107996
Open Access | Times Cited: 3
Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment
Jeffrey A. Sparks, Sara K. Tedeschi
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 9, pp. 813-815
Open Access | Times Cited: 5
Jeffrey A. Sparks, Sara K. Tedeschi
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 9, pp. 813-815
Open Access | Times Cited: 5
Severe COVID-19 outcomes among patients with autoimmune rheumatic diseases or transplantation: a population-based matched cohort study
Shelby Marozoff, Na Lu, Jonathan M. Loree, et al.
BMJ Open (2022) Vol. 12, Iss. 8, pp. e062404-e062404
Open Access | Times Cited: 5
Shelby Marozoff, Na Lu, Jonathan M. Loree, et al.
BMJ Open (2022) Vol. 12, Iss. 8, pp. e062404-e062404
Open Access | Times Cited: 5
COVID-19 Vaccination Perceptions in Patients With Rheumatic Disease: A Cross-Sectional Online Survey
Imama N. Butt, Charmaine van Eeden, Katharina Kovacs Burns, et al.
The Journal of Rheumatology (2022) Vol. 50, Iss. 5, pp. 690-696
Open Access | Times Cited: 5
Imama N. Butt, Charmaine van Eeden, Katharina Kovacs Burns, et al.
The Journal of Rheumatology (2022) Vol. 50, Iss. 5, pp. 690-696
Open Access | Times Cited: 5
COVID-19 Vaccine Effectiveness among Patients with Psoriatic Disease: A Population-Based Study
Tal Gazitt, Lihi Eder, Walid Saliba, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 453-453
Open Access
Tal Gazitt, Lihi Eder, Walid Saliba, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 453-453
Open Access
Efficacy and safety of inactivated SARS‐CoV ‐2 vaccination in COVID ‐19‐associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real‐world retrospective observational study
S. Liu, Ziyi Jin, Xuebing Feng, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 5
Closed Access
S. Liu, Ziyi Jin, Xuebing Feng, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 5
Closed Access
